Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 19, Issue 3, Pages 289-298
Publisher
SAGE Publications
Online
2012-08-04
DOI
10.1177/1352458512454771
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
- (2011) Su-Hyun Kim ARCHIVES OF NEUROLOGY
- Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
- (2011) H.H. Wang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica
- (2011) Xiaonan Zhong et al. JOURNAL OF NEUROIMMUNOLOGY
- Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica
- (2011) Sung-Min Kim et al. JOURNAL OF NEUROLOGY
- Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
- (2011) F. Jadidi-Niaragh et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis
- (2010) Makoto Hirotani et al. JOURNAL OF NEUROIMMUNOLOGY
- Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis
- (2010) F. Piazza et al. JOURNAL OF NEUROIMMUNOLOGY
- Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing−remitting multiple sclerosis patients
- (2010) Alicja Kalinowska-Łyszczarz et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population
- (2010) Adi Vaknin-Dembinsky et al. Multiple Sclerosis Journal
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- B cells as therapeutic targets in SLE
- (2010) Iñaki Sanz et al. Nature Reviews Rheumatology
- B-CELL ACTIVATING FACTOR OF THE TNF FAMILY IS UPREGULATED IN NEUROMYELITIS OPTICA
- (2010) K. Okada et al. NEUROLOGY
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- Cytokine-producing B lymphocytes—key regulators of immunity
- (2008) Frances E Lund CURRENT OPINION IN IMMUNOLOGY
- Invited Article: Inhibition of B cell functions: Implications for neurology
- (2008) M. C. Dalakas NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- The ‘short’ history of regulatory B cells
- (2007) Claudia Mauri et al. TRENDS IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started